Moderating effects of race in clinical trial participation and outcomes among marijuana-dependent young adults

Drug and Alcohol Dependence

Volumn 126, Issue 3, 2012, Pages 333-339

  Montgomery, LaTrice ^a   Petry, Nancy M ^b   Carroll, Kathleen M ^a,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Clinical trials; Disparities; Marijuana; Race

Indexed keywords

CANNABIS;

ABSTINENCE; ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CLINICAL TRIAL (TOPIC); COGNITIVE THERAPY; CONTROLLED STUDY; DRUG DEPENDENCE; EUROPEAN AMERICAN; EXPLORATORY RESEARCH; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTIVATION; PATIENT COUNSELING; PATIENT PARTICIPATION; PRIORITY JOURNAL; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNITED STATES;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; COGNITIVE THERAPY; CONTINENTAL POPULATION GROUPS; COUNSELING; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; PATIENT COMPLIANCE; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; YOUNG ADULT;

CANNABIS SATIVA;

EID: 84869220846     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2012.05.033     Document Type: Article

References (61)

1. Alegria M., Carson N.J., Goncalves M., Keefe K. Disparities in treatment for substance use disorders and co-occuring disorders for ethnic/racial minority youth. J. Am. Acad. Child Adolesc. Psychiatry 2011, 50:22-31.
2. Alvarez R.A., Vasquez E., Mayorga C.C., Feaster D.J., Mitrani V.B. Increasing minority research participation through community organization outreach. West J Nurs Res. 2006, 28:541-560.
3. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders DSM-IV-R 1994, American Psychiatric Association, Washington, DC.
4. Ball S.A., Martino S., Nich C., Frankforter T.L., Van Horn D., Crits-Christoph P., Woody G.E., Obert J.L., Farentinos C., Carroll K.M. Site matters: multisite randomized trial of motivational enhancement therapy in community drug abuse clinics. J. Consult. Clin. Psychol. 2007, 75:556-567.
5. Barry D., Sullivan B., Petry N.M. Comparable efficacy of contingency management for cocaine dependence among African American, Hispanic and White methadone maintenance clients. Psychol. Addict. Behav. 2009, 23:168-174.
6. Becker S.J., Stein G.L., Curry J.F., Hersh J. Differences among substance-abusing adolescents in a treatment dissemination project. J. Subst. Abuse Treat. 2011, [Epub ahead of print], PMID: 22000324.
7. Breland-Noble A.M., Bell C., Nicolas G. Family first: the development of an evidence-based family intervention for increasing participation in psychiatric clinical care and research in depressed African American youth. Fam. Process. 2006, 45:153-169.
8. Brody G.H., Chen Y.F., Kogan S.M., Yu T., Molgaard V.K., Diclemente R.J., Wingood G.M. Family-centered program deters substance use, conduct problems, and depressive symptoms in black adolescents. Pediatrics 2012, 129:108-115.
9. Budney A.J., Higgins S.T., Radonovich K.J., Novy P.L. Adding voucher-based incentives to coping skills and motivational enhancement improvement outcomes during treatment for marijuana dependence. J. Consult. Clin. Psychol. 2000, 68:1051-1061.
10. Budney A.J., Roffman R., Stephens R.S., Walker D. Marijuana dependence and its treatment. Addict. Clin. Prac. 2007, 4:4-16.
11. Burlew A.K., Feaster D., Brecht M.L., Hubbard R. Measurement and data analysis in research addressing health disparities in substance abuse. J. Subst. Abuse Treat. 2009, 36:25-43.
12. Burlew A.K., Weekes J.C., Montgomery L., Feaster D.J., Robbins M.S., Rosa C.L., Ruglass L.M., Venner K.L., Wu L.T. Conducting research with racial/ethnic minorities: methodological lessons from the NIDA clinical trials network. Am. J. Drug Alcohol Abuse 2011, 37:324-332.
13. Burlew A.K., Larios S., Suarez-Morales L., Holmes B., Venner K., Chavez R. Increasing ethnic minority participation in substance abuse clinical trials: lessons learned in the National Institute on Drug Abuse's Clinical Trials Network. Cultur. Divers. Ethnic Minor Psychol. 2011, 17:345-356.
14. Campbell C.I., Weisner C., Sterling S. Adolescents entering chemical dependency treatment in private managed care: ethnic differences in treatment initiation and retention. J. Adolesc. Health 2006, 38:343-350.
15. Carroll K.M., Easton C.J., Nich C., Hunkele K.A., Neavins T.M., Sinha R., Ford H.L., Vitolo S.A., Doebrick C.A., Rounsaville B.J. The use of contingency management and motivational/skills-building therapy to treat young adults with marijuana dependence. J. Consult. Clin. Psychol. 2006, 74:955-966.
16. Compton W.M., Grant B.F., Colliver J.D., Glantz M.D., Stinson F.S. Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002. JAMA 2004, 291:2114-2121.
17. Cook L.B., Alegria M. Racial-ethnic health disparities in substance abuse treatment: the role of criminal history and socioeconomic status. Psychiatr. Serv. 2011, 62:1273-1281.
18. Copeland J., Swift W. Cannabis use disorder: epidemiology and management. Int. J. Psychiatry Med. 2009, 21:96-103.
19. Corbie-Smith G., Thomas S.B., Williams M.V., Moody-Ayers S. Attitudes and beliefs of African Americans toward participation in medical research. J. Gen. Intern. Med. 2002, 14:537-546.
20. Dancy B.L., Wilbur J., Talashek M., Bonner G., Barnes-Boyd C. Community-based research: barriers to recruitment of African Americans. Nurs. Outlook. 2004, 52:234-240.
21. Dennis M., Godley S.H., Diamond G., Tims F.M., Babor T., Donaldson J., Liddle H., Titus J.C., Kaminer Y., Webb C., Hamilton N., Funk R. The Cannabis Youth Treatment (CYT) Study: main findings from two randomized trials. J. Subst. Abuse Treat. 2004, 27:197-213.
22. Dishion T.J., Kavanagh K., Schneiger A., Nelson S., Kaufman N.K. Preventing early adolescent substance use: a family-centered strategy for the public middle school. Prev. Sci. 2002, 3:191-201.
23. Ehrman R.N., Robbins J. Reliability and validity of 6-month timeline reports of cocaine and heroin use in a methadone population. J. Consult. Clin. Psychol. 1994, 62:843-850.
24. Fals-Stewart W., O'Farrell T.J., Freitas T.T., McFarlin S.K., Rutigliano P. The Timeline Followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. J. Consult. Clin. Psychol. 2000, 68:134-144.
25. Faseru B., Cox L.B., Bronars C.A., Opole I., Reed G.A., Mayo M.S., Ahluwalia J.S., Okuyemi K.S. Design, recruitment, and retention of African-American smokers in a pharmacokinetic study. BMC Med. Res. Methodol. 2010, 10:6.
26. Feldstein E.S.W., Venner K.L., Mead H.K., Bryan A.D. Exploring racial/ethnic differences in substance use: a preliminary theory-based investigation with juvenile justice-involved youth. BMC Pediatr. 2011, 16:71.
27. Fouad M.N. Enrollment of minorities in clinical trials: did we overcome the barriers?. Contemp. Clin. Trials 2009, 30:103-104.
28. Gil A.G., Wagner E.F., Tubman J.G. Culturally sensitive substance abuse intervention for Hispanic and African American adolescents: empirical examples from the Alcohol Treatment Targeting Adolescents in Need (ATTAIN) project. Addiction 2004, 99:140-150.
29. Harkley A., McLellan A., Randall M. Analysis of the Black Racial Identity Attitude scale in a substance-abusing population. J. Natl. Med. Assoc. 2002, 94:459-471.
30. Harris K.J., Ahluwalia J.S., Catley D., Okuyemi K.S., Mayo M.S., Resnicow K. Successful recruitment of minorities into clinical trials: the Kick It at Swope project. Nicotine Tob. Res. 2003, 5:575-584.
31. Heflinger C.A., Chatman J., Saunders R.C. Racial and gender differences in utilization of Medicaid substance abuse services among adolescents. Psychiatr. Serv. 2006, 57:504-511.
32. Higgins S.T., Delany D.D., Budney A.J., Bickel W., Hughes J.R., Foerg F., Fenwick J.W. A behavioral approach to achieving initial cocaine abstinence. Am. J. Psychiatry 1991, 148:1218-1224.
33. Johnson T.P., Cho Y.I., Fendrich M., Graf I., Kelly-Wilson L., Pickup L. Treatment need and utilization among youth entering the juvenile corrections system. J. Subst. Abuse Treat. 2004, 26:117-128.
34. Kadden R.M., Litt M.D., Kabela-Cormier E., Petry N.M. Abstinence rates following behavioral treatments for marijuana dependence. Addict. Behav. 2007, 32:1220-1236.
35. Kadden R.M., Litt M.D., Kabela-Cormier E., Petry N.M. Increased drinking in a trial of treatments for marijuana dependence: substance substitution?. Drug Alcohol Depend. 2009, 105:168-171.
36. Kamon J., Budney A., Stanger C. A contingency management intervention for adolescent marijuana abuse and conduct problems. J. Am. Acad. Child Adolesc. Psychiatry 2005, 44:513-521.
37. Korte J.E., Rosa C.L., Wakim P.G., Perl H.I. Addiction treatment trials: how gender, race/ethnicity, and age relate to ongoing participation and retention in clinical trials. Subst. Use Rehab. 2011, 2:205-218.
38. Liddle H.A., Rowe C.L., Dakof G.A., Ungaro R.A., Henderson C.E. Early intervention for adolescent substance abuse: pretreatment to posttreatment outcomes of a randomized clinical trial comparing multidimensional family therapy and peer group treatment. J. Psychoactive Drugs 2004, 36:49-63.
39. Litt M.D., Kadden R.M., Kabela-Cormier E., Petry N.M. Coping skills training and contingency management treatments for marijuana dependence: exploring mechanisms of behavior change. Addiction 2008, 103:638-648.
40. Lussier J.P., Heil S.H., Mongeon J.A., Badger G.J., Higgins S.T. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction 2006, 101:192-203.
41. Magruder K.M., Ouyang B., Miller S., Tilley B.C. Retention of under-represented minorities in drug abuse treatment studies. Clin. Trials 2009, 6:252-260.
42. Marijuana Treatment Project Research Group Brief treatments for cannabis dependence: findings from a randomized multisite trial. J. Consult. Clin. Psychol. 2004, 72:455-466.
43. Mercer D.E., Woody G.E. An Individual Drug Counseling Approach to Treat Cocaine Addiction: The Collaborative Cocaine Treatment Study Model 1999, National Institute of Drug Abuse, Rockville, MD.
44. Montgomery L., Burlew A.K., Kosinski A.S., Forcehimes A.A. Motivational enhancement therapy for African American substance users: a randomized clinical trial. Cultur. Divers. Ethnic Minor. Psychol. 2011, 17:357-365.
45. Moore B.A., Budney A.J. Relapse in outpatient treatment for marijuana dependence. J. Subst. Abuse Treat. 2003, 25:85-89.
46. Okuyemi K.S., Cox L.S., Nollen N.L., Snow T.M., Kaur H., Choi W., Nazir N., Mayo M.S., Ahluwalia J.S. Baseline characteristics and recruitment strategies in a randomized clinical trial of African American light-smokers. Am. J. Health Promot. 2007, 21:183-191.
47. Peters E.N., Nich C., Carroll K.M. Primary outcomes in two randomized controlled trials of treatments for cannabis use disorders. Drug Alcohol Depend. 2011, 118:408-416.
48. Releford B., Frencher S.K., Yancey A.K. Health promotion in barbershops: balancing outreach and research in African American communities. Ethn. Dis. 2010, 20:185-188.
49. Shavers-Hornaday V.L., Lynch C.F., Burmeister L.F., Torner J.C. Why are African Americans under-represented in medical research studies? Impediments to participation. Ethn. Health 1997, 2:31-45.
50. Sinha R., Easton C., Kemp K. Substance abuse treatment characteristics of probation-referred young adults in a community based outpatient program. Am. J. Drug Alcohol Abuse 2003, 29:585-597.
51. Sobell L.C., Sobell M.B. Timeline Followback: a technique for assessing self-reported alcohol consumption. Measuring Alcohol Consumption: Psychosocial and Biological Methods. 1992, 41-72. Humana Press, Totowa, NJ. R.Z. Litten, J. Allen (Eds.).
52. Stahler G.J., Kirby K.C., Kerwin M.E. A faith-based intervention for cocaine-dependent Black women. J. Psychoactive Drugs 2007, 39:183-190.
53. Stanger C., Budney A.J., Kamon J.L., Thostensen J. A randomized trial of contingency management for adolescent marijuana abuse and dependence. Drug Alcohol Depend. 2009, 105:240-247.
54. Stephens R.S., Roffman R.A., Curtin L. Comparison of extended versus brief treatments for marijuana use. J. Consult. Clin. Psychol. 2000, 68:898-908.
55. Stephens R.S., Roffman R.A., Simpson E.E. Treating adult marijuana dependence: a test of the relapse prevention model. J. Consult. Clin. Psychol. 1994, 62:92-99.
56. Substance Abuse and Mental Health Services Administration, 2010. Center for Behavioral Health Statistics and Quality. Treatment Episode Data Set (TEDS): 1998-2008. State Admissions to Substance Abuse Treatment Services, DASIS Series: S-55, HHS Publication No. (SMA) 10-4613. Rockville, MD, 2010.
57. Turner W.L., Wallace B. African American substance use: epidemiology, prevention and treatment. Violence Against Women 2003, 9:576-589.
58. Weisner C., Schmidt L.A. Expanding the frame of health services research in the drug abuse field. Health Serv. Res. 1995, 30:707-726.
59. Winhusen T., Kropp F., Babcock D., Hague D., Erickson S.J., Renz C., Rau L., Lewis D., Leimberger J., Somoza E. Motivational enhancement therapy to improve treatment utilization and outcome in pregnant substance users. J. Subst. Abuse Treat. 2008, 35:161-173.
60. Wu L.T., Woody G.E., Yang C., Pan J.J., Blazer D.G. Racial/ethnic variations in substance-related disorders among adolescents in the United States. Arch. Gen. Psychiatry 2011, 68:1176-1185.
61. Zuvekas S.H., Taliaferro G.S. Pathways to access: health insurance, the health care delivery system, and racial/ethnic health disparities, 1996-1999. Health Aff. 2003, 22:139-153.